Accessibility: Skip TopNav
CIMERLI™ (ranibizumab-eqrn) product image
CIMERLI™ (ranibizumab-eqrn) is the only FDA-approved biosimilar interchangeable with Lucentis for all Lucentis FDA-approved indications.
Format
JPEG
Source
Coherus BioSciences, Inc.
Downloads
Original
Large
Medium
Small